Cancer-Killing virus trial launches for patients out of options
Disease control
Recruiting now
This Phase 1 trial tests IDOV-Immune, a genetically engineered virus designed to infect and destroy cancer cells while boosting the immune system. It is for adults with advanced solid tumors (like colorectal, pancreatic, or lung cancer) that have not responded to standard treatme…
Phase: PHASE1 • Sponsor: ViroMissile, Inc. • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC